Disclosure to Third Parties. The Company shall have the right to disclose to third parties, in whatever manner the Company may determine, the fact that this Agreement has been executed, the names of the parties to this Agreement and the terms hereof.
Disclosure to Third Parties. (a) Notwithstanding the foregoing provisions of Section 6.1 hereof, the Parties may disclose Confidential Information belonging to the other Party:
(i) to Governmental Authorities to the extent reasonably necessary to obtain or maintain INDs or Regulatory Approvals for any Licensed Product and in order to respond to inquiries, requests, investigations, orders or subpoenas of Governmental Authorities relating to this Agreement;
(ii) to outside consultants, contractors, advisory boards, managed care organizations, and non-clinical and clinical investigators, in each case to the extent reasonably necessary to Develop, Manufacture, use or Commercialize any Licensed Product under reasonable obligations of confidentiality;
(iii) subject to Section 5.2 hereof, to the extent reasonably necessary, in connection with filing or prosecuting Patent Rights as permitted by this Agreement;
(iv) to the extent reasonably necessary, in connection with prosecuting or defending litigation as permitted by this Agreement;
(v) regarding the existence of this Agreement, this Agreement itself or the material and financial terms of this Agreement, (A) to its accountants, lawyers, and other advisers, and (B) to actual or potential investors, lenders, licensors, licensees, acquirers, investment bankers, or agents of the foregoing in connection with a financing, licensing transaction, merger, or acquisition, in each case (A)-(B) under confidentiality obligations no less restrictive than those set forth in this Agreement, provided that ImmunoGen shall not disclose the identity of the Licensed Target under clause (B) without the prior written consent of CytomX;
(vi) subject to Section 6.3.2 hereof, in connection with or included in scientific presentations and publications relating to Licensed Products, including abstracts, posters, journal articles and the like, and posting results of and other information about clinical trials to xxxxxxxxxxxxxx.xxx or PhRMA websites; and
(vii) to the extent necessary in order to enforce its rights under this Agreement.
(b) In the event a Party deems it reasonably necessary to disclose Confidential Information belonging to the other Party pursuant to Section 6.2.2(a)(i) hereof, the Disclosing Party shall to the extent possible give reasonable advance written notice of such disclosure to the other Party and take all reasonable measures to ensure confidential treatment of such information.
(c) Data generated by CytomX using Licensed Products shall not be ...
Disclosure to Third Parties. Except as expressly provided in this DPA, Webflow will not disclose Personal Data to any third party without Customer’s consent. If requested or required by a competent governmental authority to disclose the Personal Data, to the extent legally permissible and practicable, Webflow will provide Customer with sufficient prior written notice in order to permit Customer the opportunity to oppose any such disclosure.
Disclosure to Third Parties. The Vendor will not divulge, disclose, or communicate protected health information to any third party for any purpose not in conformity with this Contract without prior written approval from the Agency. The Vendor shall ensure that any agent, including a subcontractor, to whom it provides protected health information received from, or created or received by the Vendor on behalf of, the Agency agrees to the same terms, conditions, and restrictions that apply to the Vendor with respect to protected health information.
Disclosure to Third Parties. If disclosure of Confidential Information to third parties is required or allowed under this Agreement, Recipient must ensure that such third parties have express obligations of confidentiality and non-disclosure substantially similar to Recipient’s obligations hereunder. Liability for damages because of disclosure of Confidential Information by any such third parties must be borne by Recipient.
Disclosure to Third Parties. All media releases and public announcements or disclosures by any party relating to this Agreement, its subject matter, or the purpose of this Agreement are to be coordinated with and consented to by the other parties in writing prior to the release or announcement.
Disclosure to Third Parties. If an agency wishes to disclose shared information to a third party, as best practice the agency should seek written consent from the agency that provided the information. If a statutory requirement for disclosure exists then consent for further disclosure is not required. Any agency must ensure that all principles of the Data Protection Act are adhered to. Therefore, if an agency makes a further disclosure to a third party they must ensure that the sharing of personal data is not processed in any manner incompatible with the purpose/s it was obtained for.
Disclosure to Third Parties. TMLS reserves the right to distribute to third parties certain information about Subscriber, including Subscriber’s name and business address, phone number and email address. TMLS reserves the right to distribute to third parties aggregated information about Participant’s and Other Participants’ and Subscribers’ use of the TMLS Service, but not about Subscriber’s use specifically.
Disclosure to Third Parties. If performance by either party, as the receiving party, requires or allows disclosure of the Confidential Information to any third parties, then such receiving party shall ensure that such third parties will have express obligations of confidentiality and non-disclosure, with regard to the Confidential Information, similar to the receiving party’s obligations hereunder. Liability for damages due to disclosure of the Confidential Information by any such third parties shall be with the receiving party.
Disclosure to Third Parties. RMLS reserves the right to distribute to third parties certain information about Firm Participant, including Firm Participant’s and Individual Participants’ names and business addresses, phone numbers and email addresses. RMLS reserves the right to distribute to third parties aggregated information about Firm Participant’s, Individual Participants, and Other Participants’ and Subscribers’ use of the RMLS Service, but not about Firm Participant’s or Individual Participants’ use specifically.
